ELLI 40.58 Ellie Mae Inc $ELLI Hit a 52 week high of 40.99

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 11:56 AM

ELLI 40.58 Ellie Mae Inc $ELLI Hit a 52 week high of 40.99 Closing the day 09:44 at 40.58 -0.21 -0.51% With a day low of 40.71 and a total volume of 4,402.

ELLI Recent Posts: http://investorshangout.com/Ellie-Mae-ELLI-56409/

ELLI Ellie Mae Inc Recent Headline News

Ellie Mae Named to Software 500 by Software Magazine
Business Wire - Thu Nov 13, 8:03AM CST
Ellie Mae(R) (NYSE:ELLI), a leading provider of innovative on-demand software solutions and services for the residential mortgage industry, today announced that it has been named to Software Magazine's 2014 Software 500, a ranking of the top global software and service providers, now in its 32nd year. It is the fourth straight year Ellie Mae has made the list.
ELLI: 40.60 (-0.19)

Ellie Mae (ELLI) in Focus: Stock Moves 5.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:37AM CST
Ellie Mae, Inc. (ELLI) was a big mover last session, as the company saw its shares rise more than 5% on the day.
NTES: 99.05 (+1.05), ELLI: 40.60 (-0.19), RNG: 12.40 (+0.22)

JMP goes contrarian, upgrades Ellie Mae
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:23AM CST

ELLI: 40.60 (-0.19)

NYSE stocks posting largest volume increases
AP - Fri Oct 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
CCI: 80.41 (+0.20), ELLI: 40.60 (-0.19), AMBR: 11.08 (-0.35), OFC: 27.88 (-0.12), NKA: 4.63 (-0.10), RM: 12.39 (+0.03), IMPV: 44.63 (+1.24)

NYSE stocks posting largest percentage decreases
AP - Fri Oct 31, 1:49PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at 1 p.m.:
CCI: 80.41 (+0.20), ELLI: 40.60 (-0.19), TPX: 54.71 (-0.33), NKA: 4.63 (-0.10), RM: 12.39 (+0.03), GNI: 21.14 (-0.01)

Ellie Mae -14.4% due to EPS guidance
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 9:44AM CDT

ELLI: 40.60 (-0.19)

Ellie Mae beats Street 3Q forecasts
Automated Insights - Fri Oct 31, 4:04AM CDT
PLEASANTON, Calif. (AP) _ Ellie Mae Inc. (ELLI) on Friday reported net income of $4.1 million in its third quarter.
ELLI: 40.60 (-0.19)

Ellie Mae's (ELLI) CEO Sig Anderman on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 10:06PM CDT

ELLI: 40.60 (-0.19)

Ellie Mae Reports Third Quarter 2014 Results
Business Wire - Thu Oct 30, 3:07PM CDT
--Revenue Up 30% Year Over Year
ELLI: 40.60 (-0.19)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:35PM CDT

ELLI: 40.60 (-0.19), AIV: 36.40 (-0.32), EPAY: 25.44 (-0.10), CPSI: 62.29 (-0.10), LNKD: 233.28 (+3.51), ADNC: 3.79 (-0.16), CODE: 21.12 (+0.04), HME: 63.31 (-0.24), ESIO: 7.25 (+0.06), HIL: 4.01 (+0.01), DGI: 27.83 (-0.20), AHT: 10.22 (-0.06), COLM: 41.14 (+0.13), AHS: 16.19 (-0.02), CSLT: 11.79 (-0.04), FRT: 132.22 (+0.04), DGII: 7.50 (-0.04), ADUS: 21.44 (-0.04), ESS: 200.36 (-0.16), EXPE: 87.26 (+0.77), IMPV: 44.63 (+1.24), CCI: 80.41 (+0.20), CPT: 75.55 (-0.45), GB: 49.53 (-0.14), AEGR: 19.77 (-0.70), ATEN: 4.05 (-0.11), ELGX: 11.67 (-0.02), AFFX: 9.68 (-0.01), CHE: 107.71 (-0.17), BCOV: 7.09 (-0.01), DCT: 8.42 (+0.03), ELX: 5.48 (-0.03), GNMK: 10.96 (-0.34), AXTI: 2.41 (-0.02), INT: 43.88 (-0.10), EGN: 67.02 (+0.06), EGO: 6.05 (+0.30), GMED: 22.76 (-0.16), GDOT: 22.11 (+0.33), KEG: 2.48 (+0.03), ISBC: 10.81 (+0.03), GRPN: 7.72 (-0.05), ALJ: 16.41 (+0.12), CTRL: 14.88 (+0.03), GPRO: 77.54 (+1.07), EMN: 83.73 (+0.16), IMMR: 8.97 (+0.29), CUBE: 21.06 (-0.06), BYI: 81.50 (+0.02), ATRC: 18.20 (+0.15), BYD: 11.93 (-0.08), FLDM: 29.92 (+0.04), BEAT: 8.18 (+0.01), FLR: 64.61 (-0.48), FLT: 147.54 (-0.12), EHTH: 23.08 (-0.05)

Ellie Mae report sees refinancing increases in 2014
M2 - Fri Oct 24, 6:11AM CDT
Refinancings as a percentage of overall mortgage volume jumped three percent from August to account for 36 percent of closed loans in September, according to the latest origination insight report released by Ellie Mae (NYSE: ELLI).
ELLI: 40.60 (-0.19)

Latest Ellie Mae Origination Insight Report Suggests There Still May Be Life in Refis
Business Wire - Thu Oct 23, 3:15PM CDT
Refinancings as a percentage of overall mortgage volume jumped 3 percent from August to account for 36 percent of closed loans in September, according to the latest Origination Insight Report released by Ellie Mae(R) (NYSE:ELLI), a leading provider of innovative on-demand software solutions and services for the residential mortgage industry. The September 2014 report also found the closing rate on mortgage refinancings fell nearly 6 percent to 48.3 percent in September, the lowest since February.
ELLI: 40.60 (-0.19)

Can The Uptrend Continue for Ellie Mae (ELLI)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 9:00AM CDT
Can The Uptrend Continue for Ellie Mae (ELLI)?
ELLI: 40.60 (-0.19)

Ellie Mae Achieves Major Milestone with 100,000 Active Encompass Users
Business Wire - Mon Oct 20, 8:22AM CDT
Ellie Mae(R) (NYSE:ELLI), a leading provider of innovative on-demand software solutions and services for the residential mortgage industry, announced that it has recently surpassed 100,000 active users of its Encompass(R) mortgage management solution, the mortgage industry's solution for achieving compliance, loan quality and efficiency.
ELLI: 40.60 (-0.19)

Arch MI Announces Integration with Ellie Mae's Encompass(R) Mortgage Management Solution
Business Wire - Fri Oct 17, 11:08AM CDT
Arch Mortgage Insurance Company ("Arch MI"

, a leading provider of private mortgage insurance and wholly owned subsidiary of Arch Capital Group Ltd., today announced the introduction of direct integration with Ellie Mae's Encompass, a leading mortgage management solution for banks, credit unions, community banks and mortgage lenders.
ELLI: 40.60 (-0.19)

Teraverde Announces SimpleSteps Origination Manager to Increase Profitability and Compliance in Mortgage Lending
Business Wire - Thu Oct 16, 10:12AM CDT
Teraverde Management Advisors(R), a premier national consulting firm in the banking and financial industries, today announced SimpleSteps(TM) Origination Manager, designed to increase Loan Officer productivity and profitability and improve compliance for Ellie Mae(R) Encompass(R) users.
ELLI: 40.60 (-0.19)

Ellie Mae Named to HousingWire HW Fast50(TM)
Business Wire - Mon Oct 13, 11:01AM CDT
Ellie Mae(R) (NYSE: ELLI), a leading provider of innovative on-demand software solutions and services for the residential mortgage industry, announced it has made HousingWire's HW Fast50(TM) list of the 50 fastest-growing companies in the housing industry.
ELLI: 40.60 (-0.19)

Ellie Mae to Report Third Quarter 2014 Financial Results on October 30, 2014
Business Wire - Mon Oct 06, 7:30AM CDT
Ellie Mae(R) (NYSE:ELLI), a leading provider of innovative on-demand software solutions and services for the residential mortgage industry, today announced that it will release financial results for the third quarter ended September 30, 2014 following the close of the market on Thursday, October 30, 2014. The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time on that day.
ELLI: 40.60 (-0.19)

Here Are the 10 Best-Performing Technology Companies of 2014
at The Street - Sat Oct 04, 10:40AM CDT
Technology stocks outperformed the broader markets this year as the NYSE Arca Tech 100 Index gained 7.6% compared to a 1.7% gain by the NYSE Composite Index.
VDSI: 26.61 (-0.61), SNCR: 48.73 (+0.77), ELLI: 40.60 (-0.19), FB: 74.54 (+0.29), AKAM: 61.81 (+1.36), VRNT: 58.43 (-0.19), UPIP: 1.40 (unch), MSFT: 49.77 (+0.16), PANW: 110.39 (+0.79), FTNT: 27.13 (+0.21)

Company Profile for Ellie Mae, Inc.
Business Wire - Fri Oct 03, 9:20AM CDT
Ellie Mae (NYSE:ELLI) is a leading provider of innovative on-demand software solutions and services for the residential mortgage industry. Ellie Mae's all-in-one Encompass(R) mortgage management solution provides one system of record that allows banks, credit unions and mortgage lenders to originate and fund mortgages and improve compliance, loan quality and efficiency.
ELLI: 40.60 (-0.19)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....